Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
08/2000
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047194A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2360233A1 Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
08/16/2000EP1027342A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
08/16/2000EP1027328A1 Substituted anilides
08/16/2000EP1027051A1 Antithrombotic agents
08/16/2000EP0805802B1 Substituted phenyl compounds as endothelin antagonists
08/16/2000EP0738259B1 Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
08/16/2000CN1055461C Aryl acetic acid derivatives and use as germicide
08/16/2000CA2298895A1 Improved synthesis of cyclopentyl 2-thienyl ketone, tiletamine and tiletamine acid addition salts, such as tiletamine hydrochloride
08/15/2000US6103937 Producing unsaturated nitrogen containing compounds such as enamides, enamines and aryl amineslamides using as catalyst nickel and an organophosphine or carbene ligand
08/15/2000US6103754 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
08/15/2000US6103740 Methods for lowering platelet counts
08/15/2000US6103729 Cathecol derivatives and a method for the preparation thereof and a pharmaceutical composition containing the same
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/15/2000US6103708 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
08/15/2000US6103459 Lack delivered element-to-carbon bonds to reduce carbon contamination in films produced by vapor deposition; electroconductive polymers; metal complexes of the compounds; di-aza-, phospha-and/or arsa-butadiene type compounds
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/10/2000WO2000046187A2 Antizyme modulators and their use
08/10/2000WO2000046184A1 N2-phenylamidine derivatives
08/10/2000CA2362259A1 Antizyme modulators and their use
08/09/2000EP1026151A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1025083A1 Process for stereoselective synthesis of prostacyclin derivatives
08/09/2000EP0596876B1 Chelator compositions comprising alpha-diamine compounds
08/09/2000CN1262620A Beta-Alkoxyacrylates against malaria
08/09/2000CN1262270A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/09/2000CN1262269A Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
08/08/2000US6100292 Hemopoietic composition for treatment/prophylaxis of cytopenia
08/08/2000US6100263 Controlling animal pests or harmful fungi; 2-methoxyimino-2-(2'-(1?-methyl,1?-(1?'-(6??-(4??'-chlorophenyl) -hexyloxyimino) ,2?',2?'-dimethylpropyl))iminooxymethyl)-phenylacetic acid monomethylamide, for example
08/08/2000US6100220 Pesticides and herbicides
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2012661C Thienylpiperazines, process for the preparation thereof, the use thereof, and pharmaceuticals containing these and the preparation thereof
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044731A1 Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044707A1 Novel substituted guanidine derivatives and process for the preparation thereof
08/03/2000WO2000044701A1 Material for light energy storage/light-heat energy conversion
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000003975A3 Aryl vinyl ether derivatives and their use as herbicides
08/03/2000DE19903126A1 New sulphur substituted sulphonylaminocarboxylic acid N-arylamide derivatives used for treating e.g. cardiovascular diseases and atherosclerosis
08/03/2000CA2360674A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/02/2000EP1024135A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides
08/02/2000EP1024134A1 Aminobutanoic acid derivatives
08/02/2000EP1023295A1 Fibrinogen receptor antagonist prodrugs
08/02/2000EP1023283A1 Synthesis of 3-carbomethoxy-4,5-dimethylthiophene
08/02/2000EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
08/02/2000CN1261884A Benzothiophene derivatives as herbicides
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096901 Processes and intermediates for preparing 2-fluorothiophene derivatives
08/01/2000US6096781 2-phenyl-1-benzothiophene derivatives are useful for treatment of osteoporosis and hyperlipemia
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096764 Eliminating the detrimental side-effects associated with the continuous and chronic use of gondatropin-releasing hormone factor or agonist by administering to the patient an effective amount of benzothiophene derivatives
08/01/2000US6096741 Oxime derivatives, hydrazone derivatives and use thereof
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000CA2019335C Phenylalkan (en)oic acids
07/2000
07/27/2000WO2000043372A1 Acyl derivatives which treat vla-4 related disorders
07/27/2000WO2000043369A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043352A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
07/27/2000WO1999057098A3 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359076A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
07/26/2000EP1021451A1 Asymmetric synthesis and catalysis with chiral heterocyclic compounds
07/26/2000EP1021441A1 Substituted 2,4-diamino-1,3,5-triazine and their use as herbicides
07/26/2000EP1021435A1 Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
07/26/2000EP1021413A1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/26/2000EP1021410A1 Prostaglandin agonists and their use to treat bone disorders
07/26/2000EP1021402A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
07/26/2000EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS
07/26/2000CN1261349A Chalcones having antiproliferactive activity
07/26/2000CN1054742C Improvements in or relating to benzothiophenes
07/25/2000US6093744 N-acyl sulfamic acid esters useful as hypocholesterolemic agents
07/25/2000US6093735 Selective β-3 adrenergic agonists
07/25/2000US6093710 Benzothiophene derivatives, their preparation and use as urokinase inhibitors
07/20/2000WO2000042007A1 Alfa-sulfenimino acid derivatives
07/20/2000WO2000041998A1 Novel propargylether derivatives
07/20/2000WO2000041990A1 Benzophenones and the use thereof as photoinitiators
07/20/2000WO2000041531A2 Serine protease inhibitors
07/20/2000CA2356934A1 Serine protease inhibitors
07/19/2000EP1020456A1 Polyhydric phenols, epoxy resins, epoxy resin composition, and cured products thereof
07/19/2000EP1020439A1 Cetp activity inhibitors
07/19/2000EP1020427A1 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
07/19/2000EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
07/19/2000EP1019399A1 Aryl thiophene derivatives as pde iv inhibitors
07/19/2000EP1019358A1 Novel compounds, their use and preparation
07/19/2000EP1019040A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
07/19/2000EP0769001B1 2-aryl cyclopentane-1,3-dione derivatives
07/19/2000CN1260792A Treatment of central nervous system disorders with selective estrogen receptor modulators
07/19/2000CN1260345A Hydrazide compound, its preparing method and medicine compositions thereof